Influenza and the challenge for immunology

PC Doherty, SJ Turner, RG Webby, PG Thomas - Nature immunology, 2006 - nature.com
The continued westward dissemination of H5N1 influenza A viruses in avian populations
and the nearly 50% mortality rate of humans infected with H5N1 are a source of great …

The hemagglutinin: a determinant of pathogenicity

E Böttcher-Friebertshäuser, W Garten… - … and Control-Volume I, 2014 - Springer
The hemagglutinin (HA) is a prime determinant of the pathogenicity of influenza A viruses. It
initiates infection by binding to cell surface receptors and by inducing membrane fusion. The …

Deep mutational scanning of hemagglutinin helps predict evolutionary fates of human H3N2 influenza variants

JM Lee, J Huddleston, MB Doud, KA Hooper… - Proceedings of the …, 2018 - pnas.org
Human influenza virus rapidly accumulates mutations in its major surface protein
hemagglutinin (HA). The evolutionary success of influenza virus lineages depends on how …

The inherent mutational tolerance and antigenic evolvability of influenza hemagglutinin

B Thyagarajan, JD Bloom - elife, 2014 - elifesciences.org
Influenza is notable for its evolutionary capacity to escape immunity targeting the viral
hemagglutinin. We used deep mutational scanning to examine the extent to which a high …

A review of vaccine research and development: human acute respiratory infections

MP Girard, T Cherian, Y Pervikov, MP Kieny - Vaccine, 2005 - Elsevier
Worldwide, acute respiratory infections (ARIs) constitute the leading cause of acute
illnesses, being responsible for nearly 4million deaths every year, mostly in young children …

The quest for a truly universal influenza vaccine

YH Jang, BL Seong - Frontiers in cellular and infection microbiology, 2019 - frontiersin.org
There is an unmet public health need for a universal influenza vaccine (UIV) to provide
broad and durable protection from influenza virus infections. The identification of broadly …

Influenza A Virus Replication Induces Cell Cycle Arrest in G0/G1 Phase

Y He, K Xu, B Keiner, J Zhou, V Czudai, T Li… - Journal of …, 2010 - journals.asm.org
Many viruses interact with the host cell division cycle to favor their own growth. In this study,
we examined the ability of influenza A virus to manipulate cell cycle progression. Our results …

Swine influenza virus vaccines: to change or not to change—that's the question

K Van Reeth, W Ma - Swine Influenza, 2013 - Springer
Commercial vaccines currently available against swine influenza virus (SIV) are inactivated,
adjuvanted, whole virus vaccines, based on H1N1 and/or H3N2 and/or H1N2 SIVs. In …

New vaccine design and delivery technologies

M Kanekiyo, D Ellis, NP King - The Journal of Infectious …, 2019 - academic.oup.com
Technological advances in immunology, protein design, and genetic delivery have unlocked
new possibilities for vaccine concepts and delivery technologies that were previously …

Swine influenza A virus: challenges and novel vaccine strategies

E Petro-Turnquist, MJ Pekarek… - Frontiers in cellular and …, 2024 - frontiersin.org
Swine Influenza A Virus (IAV-S) imposes a significant impact on the pork industry and has
been deemed a significant threat to global public health due to its zoonotic potential. The …